Inozyme Pharma Inc. (INZY)
NASDAQ: INZY
· Real-Time Price · USD
4.00
0.00 (0.00%)
At close: Jun 30, 2025, 3:59 PM
Inozyme Pharma Ratios and Metrics
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
PE Ratio | -0.52 | -1.61 | -3.37 | -2.53 | -4.84 | -3.05 | -3.58 | -4.01 | -3.86 | -0.58 | -1.85 | -3.17 | -1.43 | -2.15 | -4.8 | -7.98 | -10.5 |
PEG Ratio | -0.22 | -0.16 | 0.30 | -0.16 | -0.56 | -0.15 | 0.21 | 0.74 | 0.20 | -0.02 | 0.35 | 0.07 | 0.14 | -0.07 | -0.36 | -0.63 | 0.46 |
PS Ratio | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
PB Ratio | 1.84 | 3.01 | 4.00 | 2.89 | 3.80 | 1.87 | 1.49 | 2.37 | 2.42 | 0.36 | 0.87 | 1.27 | 1.03 | 1.48 | 2.18 | 2.89 | 3.12 |
P/FCF Ratio | -2.01 | -9.06 | -13.49 | -11.55 | -18.38 | -14.15 | -12.63 | -16.06 | -13.96 | -2.96 | -7.98 | -12.72 | -6.83 | -11.96 | -22.14 | -39.15 | -37.22 |
P/OCF Ratio | -2.01 | -9.07 | -13.49 | -11.55 | -18.41 | -14.23 | -12.63 | -16.07 | -14.1 | -2.97 | -8.06 | -12.89 | -6.84 | -11.99 | -22.28 | -39.9 | -37.48 |
OCF/S Ratio | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Debt / Equity Ratio | 1.48 | 0.81 | 0.57 | 0.49 | 0.39 | 0.33 | 0.21 | 0.32 | 0.26 | 0.06 | 0.05 | 0.02 | 0.03 | 0.03 | 0.03 | 0.03 | 0.03 |
Quick Ratio | 2.19 | 3.56 | 7.68 | 9.84 | 14.05 | 13.36 | 16.36 | 11.89 | 10.66 | 8.93 | 11.11 | 14.55 | 8.20 | 9.92 | 14.60 | 20.22 | 21.67 |
Current Ratio | 2.19 | 3.56 | 7.68 | 9.84 | 14.05 | 13.36 | 16.36 | 11.89 | 10.66 | 8.93 | 11.11 | 14.54 | 8.20 | 9.92 | 14.60 | 20.22 | 21.67 |
Asset Turnover | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Interest Coverage | -19.69 | -19.11 | -17.55 | -19.83 | -18.37 | -6.84 | n/a | -21.26 | -56 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Return on Equity | -0.88 | -0.47 | -0.3 | -0.29 | -0.2 | -0.15 | -0.1 | -0.15 | -0.16 | -0.16 | -0.12 | -0.1 | -0.18 | -0.17 | -0.11 | -0.09 | -0.07 |
Return on Assets | -0.29 | -0.22 | -0.17 | -0.17 | -0.13 | -0.11 | -0.08 | -0.1 | -0.11 | -0.13 | -0.1 | -0.09 | -0.16 | -0.15 | -0.1 | -0.08 | -0.07 |
Return on Invested Capital | -0.35 | -0.26 | -0.19 | -0.19 | -0.15 | -0.12 | -0.09 | -0.12 | -0.13 | -0.16 | -0.11 | -0.1 | -0.17 | -0.17 | -0.11 | -0.09 | -0.07 |
Dividend Yield | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Payout Ratio | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Gross Profit Margin | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Net Profit Margin | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Pretax Profit Margin | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Profit Margin | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
FCF Margin | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
EBITDA Margin | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |